2014
DOI: 10.1159/000363537
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: Report of Seven Additional Sicilian Patients and Overview of the Overall Series from Sicily

Abstract: Background: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare recessive inherited disease caused by the mutation of the AIRE gene on chromosome 21. To date, 8 Sicilian patients have been described and the R203X AIRE mutation was found to be the most common in this region. Aims: (1) To describe 7 additional Sicilian APECED patients and to review all 15 Sicilian APECED patients who have been investigated by our group in the last years, and (2) to report a novel AIRE gene mutation.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
19
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 27 publications
(20 citation statements)
references
References 24 publications
(44 reference statements)
1
19
0
Order By: Relevance
“…Indeed, highlighting the vast phenotypic diversity of the disease, greater than 30 distinct manifestations can be seen, with more than 25 of those involving non‐endocrine organs (Lionakis, unpublished data) . Specifically, beyond the classical triad components of APECED, patients may also exhibit varying frequencies of urticarial eruption, enamel hypoplasia, intestinal malabsorption, autoimmune hepatitis, autoimmune pneumonitis, autoimmune gastritis, Sjogren's‐like syndrome, B12 deficiency, vitiligo, keratoconjuctivits, alopecia, type‐1 diabetes, tubulointerstitial nephritis and asplenia, among others (Table , Figure ) . Of interest, some of the above clinical manifestations, particularly those that target the skin, the lungs, the salivary glands, the stomach, the intestine, and the liver appear to be significantly enriched among American APECED patients compared to their frequency reported in European patient cohorts.…”
Section: Diagnosis Of the Suspected Apeced Patientmentioning
confidence: 99%
See 2 more Smart Citations
“…Indeed, highlighting the vast phenotypic diversity of the disease, greater than 30 distinct manifestations can be seen, with more than 25 of those involving non‐endocrine organs (Lionakis, unpublished data) . Specifically, beyond the classical triad components of APECED, patients may also exhibit varying frequencies of urticarial eruption, enamel hypoplasia, intestinal malabsorption, autoimmune hepatitis, autoimmune pneumonitis, autoimmune gastritis, Sjogren's‐like syndrome, B12 deficiency, vitiligo, keratoconjuctivits, alopecia, type‐1 diabetes, tubulointerstitial nephritis and asplenia, among others (Table , Figure ) . Of interest, some of the above clinical manifestations, particularly those that target the skin, the lungs, the salivary glands, the stomach, the intestine, and the liver appear to be significantly enriched among American APECED patients compared to their frequency reported in European patient cohorts.…”
Section: Diagnosis Of the Suspected Apeced Patientmentioning
confidence: 99%
“… Shown are approximate percentages of corresponding APECED manifestations pooled from various published studies comparing data from the American or other international cohorts …”
Section: Diagnosis Of the Suspected Apeced Patientmentioning
confidence: 99%
See 1 more Smart Citation
“…In Finnish, Sardinian and Iranian Jew populations APECED develops at the highest described prevalences between 1:9000-1:25,000 [9] with homozygous AIRE mutations c.769C > T, c.415C > T and c.254A > G having a founder effect respectively [8][9][10][11]. The syndrome is detected at lower incidences and with greater genetic variability [7,9,[12][13][14][15][16][17][18][19][20][21][22][23] in many European countries. American APECED patients showed a diverse clinical picture, with dramatic enrichment of organspecific non-endocrine manifestations starting early in life, compared to European cohorts [9].…”
Section: Introductionmentioning
confidence: 99%
“…No serum autoantibodies against either myelin-associated glycoprotein or peripheral nerve myelin proteins (GM1 gangliosides and onco-neural antigens-HU), CV2, amphyphysin) [6]. By radioligand binding assay, however, both of these patients demonstrated autoantibodies against P0, suggesting that P0 is an important antigen in both mice and humans deficient in Aire [13].…”
Section: Introductionmentioning
confidence: 99%